NeurologyLive® Friday 5 — December 1, 2023

News
Article

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending December 1, 2023.

Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: International Journal of MS Care: November/December 2023 Highlights

Review the latest peer-reviewed articles dedicated to the multidisciplinary management of multiple sclerosis published in the International Journal of MS Care.

International Journal of MS Care: November/December 2023 Highlights

2: Evaluating Therapeutic Targets for Deep Brain Stimulation in Parkinson Disease: Alfonso Fasano, MD, PhD

The professor of neurology at the University of Toronto provided insight on several prominent targets in the brain for deep brain stimulation, including emerging ones that may not gain as much attention. [WATCH TIME: 3 minutes]

Evaluating Therapeutic Targets for Deep Brain Stimulation in Parkinson Disease: Alfonso Fasano, MD, PhD

3: NeuroVoices: Emad Estemalik, MD, on Pioneering a New Age of Migraine Care

In this edition of NeuroVoices, the director of the headache section at Cleveland Clinic’s Neurological Institute provided thoughts on how recent advances have propelled migraine care, treatment possibilities behind prevention, and emerging research targets.

NeuroVoices: Emad Estemalik, MD, on Pioneering a New Age of Migraine Care

4: NeurologyLive® Clinician of the Month Spotlight: Patricia C. Dugan, MD

As part of our monthly clinician spotlight, NeurologyLive® highlighted epilepsy expert Patricia C. Dugan, MD, director of the epilepsy fellowship program at NYU Langone Health.

NeurologyLive® Clinician of the Month Spotlight: Patricia C. Dugan, MD

5: Biosimilars Enter the Multiple Sclerosis Treatment Paradigm

A panel of experts provide commentary on a range of topics regarding the integration of biosimilars in the management of multiple sclerosis, including the supporting data behind these agents and how the clinical community can adapt.

Biosimilars Enter the Multiple Sclerosis Treatment Paradigm
Related Videos
Sanjay R. Patel, MD, MS
Patricia K. Coyle, MD
Video 2 - 5 KOLs are featured in "Natural History of Spinal Muscular Atrophy"
Video 1 - 5 KOLs are featured in "Clinical Features and Phenotypes of Spinal Muscular Atrophy"
Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN
© 2024 MJH Life Sciences

All rights reserved.